CDIO — Cardio Diagnostics Holdings Cashflow Statement
0.000.00%
- $11.57m
- $10.24m
- $0.02m
Annual cashflow statement for Cardio Diagnostics Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Net Income/Starting Line | -0.605 | -0.62 | -4.66 | -8.38 |
Depreciation | ||||
Amortisation | ||||
Non-Cash Items | 0.589 | 0.057 | 0.113 | 2.38 |
Unusual Items | ||||
Other Non-Cash Items | ||||
Changes in Working Capital | 0.031 | -0.038 | -0.559 | 0.209 |
Change in Accounts Receivable | ||||
Change in Prepaid Expenses | ||||
Change in Other Assets | ||||
Change in Payable / Accrued Expenses | ||||
Change in Other Liabilities | ||||
Cash from Operating Activities | 0.026 | -0.585 | -5.09 | -5.67 |
Capital Expenditures | -0.03 | -0.114 | -0.076 | -0.794 |
Purchase of Fixed Assets | ||||
Purchase / Acquisition of Intangibles | ||||
Other Investing Cash Flow Items | 0 | -0.25 | -0.292 | 0 |
Acquisition of Business | ||||
Sale of Business | ||||
Other Investing Cash Flow | ||||
Cash from Investing Activities | -0.03 | -0.364 | -0.368 | -0.794 |
Financing Cash Flow Items | — | — | -2.73 | -0.315 |
Other Financing Cash Flow | ||||
Net Issuance / Retirement of Stock | ||||
Net Issuance / Retirement of Debt | ||||
Cash from Financing Activities | 0.24 | 1.23 | 9.06 | 3.63 |
Beginning Cash Balance | ||||
Ending Cash Balance | ||||
Net Change in Cash | 0.236 | 0.276 | 3.6 | -2.83 |